Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
October 4, 2023 9:54 PM 2 min read

Cathie Wood's Ark Invest Sells Over $25M Worth Of Tesla Shares Amid Boost In Price

by Benzinga Neuro Benzinga Staff Writer
Follow
FlipboardIcon version of the Flipboard logo

On Wednesday, October 4, 2023, Cathie Wood-led Ark Invest made a significant move by selling over $25 million worth of Tesla Inc (NASDAQ:TSLA) shares. This divestment is a notable shift, given Ark's previous bullish stance on the electric car maker, indicating a nuanced approach to portfolio management amidst evolving market dynamics.

The Tesla Trade

Ark sold a total of 97,599 worth of Tesla shares through its flagship ARK Innovation ETF (NYSE:ARKK) and through ARK Autonomous Technology & Robotics ETF (BATS:ARKQ) and ARK Next Generation Internet ETF (NYSE:ARKW). The value of the sale was $25.49, based on the closing price of $261.16 on Wednesday. Tesla stock rose by 5.9% over 24 hours in value.

Ark Invest's decision to offload a significant portion of the Elon Musk-ed company’s shares underscores a strategic realignment. The fund's move is particularly striking given Cathie Wood's historical advocacy for Tesla.

The sale could suggest a recalibration of Ark's investment strategy, possibly in response to emerging market trends and opportunities, as detailed in a previous analysis of Tesla's projected $2,000 price target.

See Also: Here's How Much $1,000 Invested In Tesla Stock Will Be Worth If It Hits Cathie Wood's Price Target

Other Key Trades:

Photo courtesy Benzinga YouTube and Unsplash

Read Next: Exclusive: Cathie Wood Tells Benzinga Why Tesla Should Trade As A Tech Stock

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
EquitiesNewsMarketsMediaETFsARK InvestArk Invest ManagementCathie Woodelectric vehiclesEVsTesla
ARKG Logo
ARKGARK Genomic Revolution ETF
$28.300.64%
Overview
ARKK Logo
ARKKARK Innovation ETF
$72.33-0.10%
ARKQ Logo
ARKQARK Autonomous Technology & Robotics ETF
$117.31-1.17%
ARKW Logo
ARKWARK Next Generation Internet ETF
$128.020.24%
CRSP Logo
CRSPCRISPR Therapeutics AG
$56.08-0.74%
DNA Logo
DNAGinkgo Bioworks Holdings Inc
$6.550.77%
NVDA Logo
NVDANVIDIA Corp
$178.030.12%
PACB Logo
PACBPacific Biosciences of California Inc
$1.412.17%
TSLA Logo
TSLATesla Inc
$394.69-0.51%
  • Ark Invest purchased 20,948 shares of Pacific Biosciences of California (NASDAQ:PACB) through ARKK.
  • The acquisition of 19,399 shares of CRISPR Therapeutics AG (NASDAQ:CRSP) through ARKK
  • A substantial investment was made in Ginkgo Bioworks Holdings Inc (NYSE:DNA) through ARKK.
  • Sale of 15,262 shares of Nvidia Corporation (NASDAQ:NVDA) through ARK Genomic Revolution ETF (BATS:ARKG).

Engineered by Benzinga Neuro, Edited by Shivdeep Dhaliwal


The GPT-4-based Benzinga Neuro content generation system exploits the extensive Benzinga Ecosystem, including native data, APIs, and more to create comprehensive and timely stories for you. Learn more.


ARKG Logo
ARKGARK Genomic Revolution ETF
$28.300.64%
Overview
ARKK Logo
ARKKARK Innovation ETF
$72.33-0.10%
ARKQ Logo
ARKQARK Autonomous Technology & Robotics ETF
$117.31-1.17%
ARKW Logo
ARKWARK Next Generation Internet ETF
$128.020.24%
CRSP Logo
CRSPCRISPR Therapeutics AG
$56.08-0.74%
DNA Logo
DNAGinkgo Bioworks Holdings Inc
$6.550.77%
NVDA Logo
NVDANVIDIA Corp
$178.030.12%
PACB Logo
PACBPacific Biosciences of California Inc
$1.412.17%
TSLA Logo
TSLATesla Inc
$394.69-0.51%
Comments
Loading...